Annovis Bio

Home » Annovis Bio

IPO

Annovis Bio

Pharmaceutical

Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).

Symbol

ANVS

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

To view the prospectus for Annovis Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253